IniXium
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2350 Rue Cohen, St Laurent, Manitoba, R0...Phone Number
(450) 680-3305Website
www.inixium.comRevenue
<$5 MillionIndustry
About IniXium
IniXium is a privately owned contract research organization (CRO) specializing in providing services to the drug discovery community. It offers a comprehensive range of services, including protein production, biophysical characterization, protein crystallography, fragment screening, and support for biologics and biosimilars. Targeting clients in sectors such as biotech, pharma, venture capital, law firms, and other CROs, IniXium is committed to delivering critical and reliable scientific information. With a focus on excellence and partnership, IniXium aims to be a trusted ally for any drug hunter in their research efforts.Explore more
IniXium Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to IniXium
Compare insights from companies similar to IniXium, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
IniXium Tech Stack
A closer look at the technologies used by IniXium
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding IniXium
Sign Up For FreeTo access detailed company insights
IniXium is a privately owned contract research organization (CRO) specializing in providing services to the drug discovery community. It offers a comprehensive range of services, including protein production, biophysical characterization, protein crystallography, fragment screening, and support for biologics and biosimilars. Targeting clients in se... Read More
